Point72 Asia (Singapore)’s Insmed INSM Stock Holding History

Point72 Asia (Singapore)’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.07M	Buy	14,371 +8,901	+163%	+$1.09M	0.32%	63
2025 Q2	$551K	Buy	+5,470	New	+$418K	0.1%	190
2024 Q3	–	Sell	-8,513	Closed	-$570K	–	1150
2024 Q2	$570K	Buy	8,513 +5,206	+157%	+$202K	0.12%	143
2024 Q1	$89.7K	Buy	+3,307	New	+$92.6K	0.02%	677

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Point72 Asia (Singapore)'s INSM Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its Insmed (INSM) stake by 163% in Q3 2025, buying an estimated $1.09M and bringing the position to 14,371 shares worth $2.07M. The position accounts for 0.32% of the portfolio, ranked #63.

Point72 Asia (Singapore) first reported a position in INSM in Q1 2024 and has held it in 4 quarters since. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

Point72 Asia (Singapore) held 14,371 shares of Insmed worth $2.07M as of Q3 2025.
Point72 Asia (Singapore) bought 8,901 Insmed shares in Q3 2025, an estimated $1.09M.
Insmed made up 0.32% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #63 holding.
Point72 Asia (Singapore) first reported a position in Insmed in Q1 2024 and has held it in 4 quarters since.
566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.